• Profile
Close

A 5-serum miRNA panel for the early detection of colorectal cancer

OncoTargets and Therapy May 16, 2018

Guo S, et al. - Researchers intended to screen microRNAs (miRNAs) that can be used for the early detection of colorectal cancer (CRC) based on differential expression of miRNA in serum, in a three-stage study with 217 CRCs, 168 colorectal adenomas (CRAs), and 190 healthy controls (HCs). A receiver operating characteristic curve was drawn to evaluate the diagnostic accuracy. With high sensitivity and specificity (91.6% sensitivity and 91.7% specificity), a 5-serum miRNA panel (miRNA-1246, miRNA-202-3p, miRNA-21-3p, miRNA-1229-3p, and miRNA-532-3p) provided an effective discrimination of CRCs from HCs. The 5-serum miRNA panel may be a promising prospect for application as a nonintrusive and inexpensive method for the early detection of CRC.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay